-
公开(公告)号:US20020198180A1
公开(公告)日:2002-12-26
申请号:US10163684
申请日:2002-06-05
IPC分类号: A61K031/655 , C07D499/46 , A61K031/5377 , A61K031/431 , A61K031/43
CPC分类号: C07D499/00
摘要: Compounds of formula I: 1 wherein R1, R2, R3, R4 and n have any of the values defined in the specification, and their pharmaceutically acceptable salts, are useful for inhibiting null-lactamase enzymes, for enhancing the activity of null-lactam antibiotics, and for treating null-lactam resistant bacterial infections in a mammal. The invention also provides pharmaceutical compositions, processes for preparing compounds of formula I, and novel intermediates useful for the synthesis of compounds of formula I.
摘要翻译: 式I化合物:其中R1,R2,R3,R4和n具有说明书中定义的任何值及其药学上可接受的盐,可用于抑制β-内酰胺酶,用于增强β-内酰胺抗生素的活性, 并用于治疗哺乳动物中的β-内酰胺抗性细菌感染。 本发明还提供药物组合物,制备式I化合物的方法和可用于合成式I化合物的新中间体。
-
公开(公告)号:US20030004195A1
公开(公告)日:2003-01-02
申请号:US10158685
申请日:2002-05-30
申请人: Alteon, Inc.
发明人: Martin Gall
IPC分类号: A61K031/427 , A61K031/4178 , A61K031/422 , A61K031/4245 , A61K031/431
CPC分类号: A61K31/427 , A61K31/4178 , A61K31/422 , A61K31/4245 , A61K31/431
摘要: Provided, among things, is a method of decreasing intraocular pressure in an animal, including a human, comprising administering an intraocular pressure decreasing amount of a compound of the formula I: 1
摘要翻译: 本发明提供了包括人在内的动物降低眼内压的方法,其包括施用眼内压降低量的式I化合物:
-